Refine your search
Collections
Co-Authors
Journals
Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All
Sekar, Ramya
- Conspectus of SARS-CoV-2 - In India
Abstract Views :98 |
PDF Views:74
Authors
Affiliations
1 Department of Oral Pathology and Microbiology, Meenakshi Ammal Dental College and Hospital, Chennai - 600095, Tamil Nadu, IN
2 Priyadharshini Dental College and Hospital, Thiruvallur - 631203, Tamil Nadu, IN
1 Department of Oral Pathology and Microbiology, Meenakshi Ammal Dental College and Hospital, Chennai - 600095, Tamil Nadu, IN
2 Priyadharshini Dental College and Hospital, Thiruvallur - 631203, Tamil Nadu, IN
Source
Journal of Natural Remedies, Vol 23, No 1 (2023), Pagination: 13-22Abstract
COVID-19 has created much concern among general public, policy makers and especially heath care workers. The reason is not one but varied such as anxiety, fear, compromised health, isolation, economic crisis and social stigma all of which leads to psychological stress. The disease became a global concern due to unmanageable death even in much developed countries. Coronavirus disease 19 (COVID -19) is a newly discovered disease caused by coronavirus which reside both in humans and animals. The article is a detailed review from the origin of the disease, its progression in India and its various other aspects.Keywords
Covid 19, SARS Cov2, Viral.References
- Hu B, Guo H, Zhou P, Shi ZL. Characteristics of SARS-CoV-2 and COVID-19. Nature Reviews Microbiology. 2021; 19(3):141-154. https://doi. org/10.1038/s41579-020-00459-7
- Sivapathasundharam B, Gururaj N, Ranganathan K. Viral infections. In: Sivapathasundharam B, Adaptation editor. Shafers Textbook of Oral pathology. 9th ed. India: Elsevier. 2021; p. 327.
- Wu Y, Ho W, Huang Y, Jin DY, Li S, Liu SL, Zheng ZM. SARS-CoV-2 is an appropriate name for the new coronavirus. The Lancet. 2020; 395(10228):949-950. https://doi.org/10.1016/S0140-6736(20)30557-2
- Alexander E Gorbalenya, Susan C Baker, Ralph S Baric, Raoul Jnde Groot, Christian Drosten, Anastasia A Gulyaeva, et al. The species severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nature Microbiology. 2020; 5(4):536. https://doi. org/10.1038/s41564-020-0695-z
- Cui J, Li F, Shi ZL. Origin and evolution of pathogenic coronaviruses. Nature Reviews Microbiology. 2019; 17(3):181-92. https://doi.org/10.1038/s41579-018- 0118-9
- Abdelrahman Z, Li M, Wang X. Comparative review of SARS-CoV-2, SARS-CoV, MERS-CoV, and influenza a respiratory viruses. Frontiers in immunology. 2020; 11:2309. https://doi.org/10.3389/fimmu.2020.552909
- Dong E, Du H, Gardner L. An interactive webbased dashboard to track COVID-19 in real time.The Lancet infectious diseases. 2020; 20(5):533-534. https://doi.org/10.1016/S1473-3099(20)30120-1
- Anand S, Mayya YS. Size distribution of virus laden droplets from expiratory ejecta of infected subjects. Scientific Reports. 2020; 10(1):1-9. https://doi. org/10.1038/s41598-020-78110-x
- Hu B, Guo H, Zhou P, Shi ZL. Characteristics of SARS-CoV-2 and COVID-19. Nature Reviews Microbiology. 2021; 19(3):141-154. https://doi. org/10.1038/s41579-020-00459-7
- V’kovski P, Kratzel A, Steiner S, Stalder H, Thiel V. Coronavirus biology and replication: implications for SARS-CoV-2. Nature Reviews Microbiology. 2021; 19(3):155-170. https://doi.org/10.1038/s41579-020- 00468-6
- Corman VM, Muth D, Niemeyer D, Drosten C. Hosts and sources of endemic human coronaviruses. Advances in virus research. 2018; 100:163-188. https://doi.org/10.1016/bs.aivir.2018.01.001
- Gorbalenya AE, Enjuanes L, Ziebuhr J, Snijder EJ. Nidovirales: evolving the largest RNA virus genome. Virus research. 2006; 117(1):17-37. https://doi. org/10.1016/j.virusres.2006.01.017
- Chiara M, D’Erchia AM, Gissi C, Manzari C, Parisi A, Resta N, Pesole G. Next generation sequencing of SARS-CoV-2 genomes: challenges, applications and opportunities. Briefings in Bioinformatics. 2021; 22(2):616-630. https://doi.org/10.1093/bib/bbaa297
- Zeng W, Liu G, Ma H, Zhao D, Yang Y, Liu M, Jin T. Biochemical characterization of SARS-CoV-2 nucleocapsid protein. Biochemical and biophysical research communications. 2020; 527(3):618-623. https://doi.org/10.1016/j.bbrc.2020.04.136
- Yurkovetskiy L, Wang X, Pascal K. E, TomkinsTinch C, Nyalile TP, Wang Y, Luban J. Structural and functional analysis of the D614G SARS-CoV-2 spike protein variant. Cell. 2020; 183(3):739-751. https:// doi.org/10.1016/j.cell.2020.09.032
- Ye Q, West AM, Silletti S, Corbett KD. Architecture and self‐assembly of the SARS‐CoV‐2 nucleocapsid protein. Protein Science. 2020; 29(9):1890-1901. https://doi.org/10.1002/pro.3909
- Perdikari TM, Murthy AC, Ryan VH, Watters S, Naik MT, Fawzi NL. SARS‐CoV‐2 nucleocapsid protein phase‐separates with RNA and with human hnRNPs. The EMBO Journal. 2020; 39(24):e106478. https:// doi.org/10.15252/embj.2020106478
- Harvey WT, Carabelli AM, Jackson B, Gupta RK, Thomson EC, Harrison EM, Robertson DL. SARSCoV-2 variants, spike mutations and immune escape. Nature Reviews Microbiology. 2021; 19(7):409-424. https://doi.org/10.1038/s41579-021-00573-0
- Koyama T, Platt D, Parida L. Variant analysis of SARS-CoV-2 genomes. Bulletin of the World Health Organization. 2020; 98(7):495. https://doi. org/10.2471/BLT.20.253591
- Rambaut A, Holmes EC, O’Toole A, Hill V, McCrone JT, Ruis C, Pybus, OG. A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology. Nature microbiology. 2020; 5(11):1403- 1407. https://doi.org/10.1038/s41564-020-0770-5
- Karia R, Gupta I, Khandait H, Yadav A, Yadav, A. COVID-19 and its Modes of Transmission. SN Comprehensive Clinical Medicine. 2020; 1-4. https:// doi.org/10.1007/s42399-020-00498-4
- Rahman HS, Aziz MS, Hussein RH, Othman HH, Omer SHS, Khalid ES, Abdullah R. The transmission modes and sources of COVID-19: A systematic review. International Journal of Surgery Open. 2020; 26:125-136. https://doi.org/10.1016/j.ijso.2020.08.017
- Perl SH, Uzan-Yulzari A, Klainer H, Asiskovich L, Youngster M, Rinott E, Youngster I. SARS-CoV-2- Specific Antibodies in Breast Milk After COVID-19 Vaccination of Breastfeeding Women. Jama. 2021; 325(19):2013-2014. https://doi.org/10.1001/ jama.2021.5782
- Iftimie S, Lopez-Azcona AF, Vallverdu I, HernandezFlix S, De Febrer G, Parra S, Castro A. First and second waves of coronavirus disease-19: A comparative study in hospitalized patients in Reus, Spain. PloS one 2021; 16(3):e0248029. https://doi.org/10.1371/journal. pone.0248029
- Pedro SA, Ndjomatchoua FT, Jentsch P, Tchuenche JM, Anand M, Bauch CT. Conditions for a second wave of COVID-19 due to interactions between disease dynamics and social processes. Frontiers in Physics. 2020; 8:428. https://doi.org/10.3389/ fphy.2020.574514
- Thorlund K, Dron L, Park J, Hsu G, Forrest JI, Mills EJ. A real-time dashboard of clinical trials for COVID19. The Lancet Digital Health. 2020; 2(6):e286-e287. https://doi.org/10.1016/S2589-7500(20)30086-8
- Kumar N, Hameed SKS, Babu GR, Venkataswamy MM, Dinesh P, Bg PK, Ravi V. Descriptive epidemiology of SARS-CoV-2 infection in Karnataka state, South India: Transmission dynamics of symptomatic vs. asymptomatic infections. EClinicalMedicine. 2021; 32:100717. https://doi. org/10.1016/j.eclinm.2020.100717
- Laxminarayan R, Wahl B, Dudala SR, Gopal K, Neelima S, Reddy KJ, Lewnard JA. Epidemiology and transmission dynamics of COVID-19 in two Indian states. Science. 2020; 370(6517):691-697. https://doi. org/10.1126/science.abd7672
- Perlman S, Netland J. Coronaviruses post-SARS: update on replication and pathogenesis. Nature reviews microbiology. 2009; 7(6):439-450. https://doi. org/10.1038/nrmicro2147
- Liu DX, Fung TS, Chong KKL, Shukla A, Hilgenfeld R. Accessory proteins of SARS-CoV and other coronaviruses. Antiviral Research. 2014; 109:97-109. https://doi.org/10.1016/j.antiviral.2014.06.013
- Letko M, Marzi A, Munster V. Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses. Nature Microbiology. 2020; 5(4):562-569. https://doi. org/10.1038/s41564-020-0688-y
- Cui J, Li F, Shi ZL. Origin and evolution of pathogenic coronaviruses. Nature Reviews Microbiology. 2019; 17(3):181-192. https://doi.org/10.1038/s41579-018- 0118-9
- Hoffmann M, Kleine-Weber H, Schroeder S, Kruger N, Herrler T, Erichsen S, Pohlmann S. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020; 181(2):271-280. https://doi.org/10.1016/j. cell.2020.02.052
- Robson F, Khan KS, Le TK, Paris C, Demirbag S, Barfuss P, Ng WL. Coronavirus RNA proofreading: molecular basis and therapeutic targeting. Molecular Cell. 2020; 80(6):1136-1138. https://doi.org/10.1016/j. molcel.2020.11.048
- Gubernatorova EO, Gorshkova EA, Polinova AI, Drutskaya MS. IL-6: relevance for immunopathology of SARS-CoV-2. Cytokine and growth factor reviews. 2020; 53:13-24. https://doi.org/10.1016/j. cytogfr.2020.05.009
- Cui X, Chen W, Zhou H, Gong Y, Zhu B, Lv X, Ma H. Pulmonary Edema in COVID-19 Patients: Mechanisms and Treatment Potential. Frontiers in Pharmacology. 2021; 12:1444. https://doi. org/10.3389/fphar.2021.664349
- Teuwen LA, Geldhof V, Pasut A, Carmeliet P. COVID-19: the vasculature unleashed. Nature Reviews Immunology. 2020; 20(7):389-391. https:// doi.org/10.1038/s41577-020-0343-0
- Hotchkiss RS, Moldawer LL, Opal SM, Reinhart K, Turnbull IR, Vincent JL. Sepsis and septic shock. Nature reviews Disease primers. 2016; 2(1):1-21. https://doi.org/10.1038/nrdp.2016.45
- Pool R, Gomez H, Kellum JA. Mechanisms of organ dysfunction in sepsis. Critical care clinics. 2018; 34(1):63-80. https://doi.org/10.1016/j. ccc.2017.08.003
- Thevarajan I, Buising KL, Cowie BC. Clinical presentation and management of COVID-19. Med J Aust. 2020; 213(3):134-139. https://doi.org/10.5694/ mja2.50698
- Kar SK, Ransing R, Arafat SY, Menon V. Second wave of COVID-19 pandemic in India: Barriers to effective governmental response. EClinical Medicine. 2021; 36. https://doi.org/10.1016/j.eclinm.2021.100915
- Hunt RH, East JE, Lanas A, Malfertheiner P, Satsangi J, Scarpignato C, Webb GJ. COVID-19 and Gastrointestinal Disease: Implications for the Gastroenterologist. Digestive Diseases. 2021; 39(2):119-139. https://doi.org/10.1159/000512152
- Tang D, Comish P, Kang R. The hallmarks of COVID19 disease. PLoS pathogens. 2020; 16(5):e1008536. https://doi.org/10.1371/journal.ppat.1008536
- Gregorevic K, Maier A, Miranda R, Loveland P, Miller K, Buising K, Lim K. Presenting symptoms of COVID‐19 and clinical outcomes in hospitalised older adults. Internal Medicine Journal. 2021; 51(6):861-867 https://doi.org/10.1111/imj.15286
- Udugama B, Kadhiresan P, Kozlowski HN, Malekjahani A, Osborne M, Li VY, Chan WC. Diagnosing COVID-19: the disease and tools for detection. ACS nano. 2020; 14(4):3822-3835. https:// doi.org/10.1021/acsnano.0c02624
- La Marca A, Capuzzo M, Paglia T, Roli L, Trenti T, Nelson SM. Testing for SARS-CoV-2 (COVID-19): A systematic review and clinical guide to molecular and serological in vitro diagnostic assays. Reproductive Biomedicine Online. 2020; 41(3):483-499. https:// doi.org/10.1016/j.rbmo.2020.06.001
- Huang I, Pranata R, Lim MA, Oehadian A, Alisjahbana B. C-reactive protein, procalcitonin, D-dimer, and ferritin in severe coronavirus disease-2019: A meta-analysis. Therapeutic advances in respiratory disease. 2020; 14:1753466620937175. https://doi. org/10.1177/1753466620937175
- Li M. Chest CT features and their role in COVID-19. Radiology of Infectious Diseases. 2020; 7(2):51-54. https://doi.org/10.1016/j.jrid.2020.04.001
- Prokop M, Van Everdingen W, van Rees Vellinga T, Quarles van Ufford H, Stoger L, Beenen L. COVID-19 Standardized Reporting Working Group of the Dutch Radiological Society. CO-RADS: A categorical CT assessment scheme for patients suspected of having COVID-19-definition and evaluation. Radiology. 2020; 296(2):E97-E104. https://doi.org/10.1148/ radiol.2020201473
- World Health organization. COVID-19 clinical management: living guidance. World Health organization. 2021. (No. WHO/2019-nCoV/ clinical/2021.1).
- Lamontagne F, Agoritsas T, Macdonald H, Leo YS, Diaz J, Agarwal A, Vandvik, PO. A living WHO guideline on drugs for covid-19. BMJ (Clinical Research Edition). 2020; 370:m3379.
- Elliott JH, Jeppesen BT. Rapid and Living Guidance for COVID-19. Annals of Internal Medicine. 2021; M21-2245. https://doi.org/10.7326/M21-2245
- Kalil AC, Patterson TF, Mehta AK, Tomashek KM, Wolfe CR, Ghazaryan V, Beigel JH. Baricitinib plus remdesivir for hospitalized adults with Covid-19. New England Journal of Medicine. 2021; 384(9):795- 807. https://doi.org/10.1056/NEJMoa2031994
- Loi M, Branchford B, Kim J, Self C, Nuss R. COVID‐19 anticoagulation recommendations in children. Pediatric Blood and Cancer. 2020; 67(9):e28485. https://doi.org/10.1002/pbc.28485
- Samaranayake LP, Seneviratne CJ, Fakhruddin KS. Coronavirus disease 2019 (COVID‐19) vaccines: A concise review. Oral Diseases. 2021; 15:10.1111/ odi.13916. https://doi.org/10.1111/odi.13916
- Choudhary OP, Choudhary P, Singh I. India’s COVID-19 vaccination drive: key challenges and resolutions. The Lancet. Infectious Diseases. 2021; 21(11):1483-1484. https://doi.org/10.1016/S1473- 3099(21)00567-3
- Shin MD, Shukla S, Chung YH, Beiss V, Chan SK, Ortega-Rivera OA, Steinmetz NF. COVID-19 vaccine development and a potential nanomaterial path forward. Nature Nanotechnology. 2020; 15(8):646- 655. https://doi.org/10.1038/s41565-020-0737-y
- Pollard AJ, Bijker EM. A guide to vaccinology: from basic principles to new developments. Nature Reviews Immunology. 2021; 21(2):83-100. https:// doi.org/10.1038/s41577-020-00479-7
- Yadav PD, Ella R, Kumar S, Patil DR, Mohandas S, Shete AM, Bhargava B. Immunogenicity and protective efficacy of inactivated SARS-CoV-2 vaccine candidate, BBV152 in rhesus macaques. Nature Communications. 2021; 12(1):1-11. https:// doi.org/10.1038/s41467-021-21639-w
- Sapkal GN, Yadav D, Sahay R. Neutralization of Delta variant with sera of Covishield™ vaccinees and COVID-19. J Travel Med. 2021; 28(7):taab119. https://doi.org/10.1093/jtm/taab119
- Momin T, Kansagra K, Patel H, Sharma S, Sharma B, Patel J, Parmar D. Safety and Immunogenicity of a DNA SARS-CoV-2 vaccine (ZyCoV-D): Results of an open-label, non-randomized phase I part of phase I/II clinical study by intradermal route in healthy subjects in India. EClinical Medicine. 2021; 38:101020. https:// doi.org/10.1016/j.eclinm.2021.101020
- Logunov DY, Dolzhikova IV, Shcheblyakov DV, Tukhvatulin AI, Zubkova OV, Dzharullaeva AS. GamCOVID-Vac Vaccine Trial Group. Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: An interim analysis of a randomised controlled phase 3 trial in Russia. The Lancet. 2021; 397(10275):671-681. https://doi. org/10.1016/S0140-6736(21)00234-8
- Vaccination Dose Status. Government of India. Available from: https://www.mygov.in/covid-19. Accessed on 08th October, 2021.
- COVID C, Team R. SARS-CoV-2 B. 1.1. 529 (Omicron) Variant-United States, December 1-8, 2021. Morbidity and Mortality Weekly Report. 2021; 70(50):1731. https://doi.org/10.15585/mmwr. mm7050el